NeuBase Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2023 was $122.000, a 95.5% decline year-over-year.
  • NeuBase Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2023 was $5.07K, a 78.9% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2022 was $24K, a 25.6% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2021 was $32.3K, a 321% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2020 was $7.69K, a 94% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $5.07K $122 -$2.57K -95.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.65K $730 -$2.09K -74.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $9.73K $2.35K -$962 -29% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $10.7K $1.87K -$13.4K -87.7% Oct 1, 2022 Dec 31, 2022 10-QT 2023-06-05
Q3 2022 $24K $2.69K -$10.4K -79.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $34.4K $2.82K -$255 -8.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $34.7K $3.32K -$3.14K -48.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $37.8K $15.2K +$5.48K +56.3% Oct 1, 2021 Dec 31, 2021 10-QT 2023-06-05
Q3 2021 $32.3K $13.1K +$8.6K +193% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-21
Q2 2021 $23.7K $3.07K +$1.5K +95.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $22.2K $6.46K +$6.12K +1789% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $16.1K $9.74K +$8.43K +643% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 $7.69K $4.46K -$5.3K -54.3% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 $13K $1.57K -$59.4K -97.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $72.4K $342 -$43.3K -99.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $116K $1.31K -$13.3K -91% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $129K $9.76K Jul 1, 2019 Sep 30, 2019 10-K 2020-12-23
Q2 2019 $60.9K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $43.6K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $14.6K Oct 1, 2018 Dec 31, 2018 10-Q 2020-03-26
Q3 2015 $5.98K $1.62K Jul 1, 2015 Sep 30, 2015 10-K 2015-12-14
Q2 2015 $2.82K -$758 -21.2% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $1.1K Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $433 -$80 -15.6% Oct 1, 2014 Dec 31, 2014 10-Q/A 2015-02-10
Q2 2014 $3.58K +$594 +19.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q4 2013 $513 -$46 -8.23% Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-10
Q2 2013 $2.99K +$2.08K +230% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-18
Q4 2012 $559 Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q2 2012 $906 +$822 +979% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q3 2011 $2.43K $0 Jul 1, 2011 Sep 30, 2011 10-K 2013-01-09
Q2 2011 $84.00 -$2.41K -96.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $169 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 $2.18K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-02-14
Q2 2010 $2.5K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.